Cargando…
Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease
The core Alzheimer's disease (AD) cerebrospinal fluid (CSF) biomarkers; amyloid-β (Aß), total tau (t-tau), and phosphorylated tau (p-tau181), are strong indicators of the presence of AD pathology, but do not correlate well with disease progression, and can be difficult to implement in longitudi...
Autores principales: | Carlyle, Becky C., Kitchen, Robert R., Mattingly, Zoe, Celia, Amanda M., Trombetta, Bianca A., Das, Sudeshna, Hyman, Bradley T., Kivisäkk, Pia, Arnold, Steven E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207419/ https://www.ncbi.nlm.nih.gov/pubmed/35734478 http://dx.doi.org/10.3389/fneur.2022.889647 |
Ejemplares similares
-
Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2023) -
Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease
por: Bryant, Annie G., et al.
Publicado: (2020) -
Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias
por: Carlyle, Becky C., et al.
Publicado: (2018) -
Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2022) -
Identification of Plasma Inflammatory Markers of Adolescent Depression Using the Olink Proteomics Platform
por: Yang, Ling, et al.
Publicado: (2023)